| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |